200 Years of LGBTQIA+ History

From Shadows to Pride — UK & Global Timeline

Source Record

Skriftlig spørsmål fra Dag-Inge Ulstein (KrF) om utprøvende behandling for kjønnsinkongruens (Dokument 15:2665, 2024-2025)

Why this source is used

Official Stortinget written question (answered 2 July 2025 by Health Minister Vestre) confirming the regional health enterprises supported Ukom's recommendation to define medical treatment of minors as utprøvende behandling (experimental) and tasked Oslo University Hospital with a prospective clinical study. The fagdirektør classification decision was internal (late 2023) and first reported February 2024; no public official document dated February 2024 exists, so this 2025 parliamentary answer is the official confirmation of the substance.

Source Status

Publisher
Stortinget (Norwegian Parliament)
Type
government
Reliability
high
Cited by
1 pages

Source Links

Open original source https://www.stortinget.no/no/Saker-og-publikasjoner/Sporsmal/Skriftlige-sporsmal-og-svar/Skriftlig-sporsmal/?qnid=106242 Accessed 12 August 2026

Used by Timeline Events

February 2024 HealthInternationalTrans

Norway Formally Classifies Youth Puberty Blockers as Experimental

The medical directors of Norway's four regional health authorities determined that puberty blockers and cross-sex hormones for gender-distressed minors constitute experimental treatments and must be restricted to clinical trials only. Under the new policy, these treatments would no longer be available as routine interventions from specialist services, private providers, or family doctors.